Tomuzotuximab
Modify Date: 2024-04-06 12:39:30
Tomuzotuximab structure
|
Common Name | Tomuzotuximab | ||
|---|---|---|---|---|
| CAS Number | 1646321-00-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TomuzotuximabTomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects[1]. |
| Name | Tomuzotuximab |
|---|
| Description | Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Tomuzotuximab has a fully human glycosylation pattern and is glyco-optimised at its Fc domain, while fully retaining the affinity, specificity, EGFR inhibition and induction of apoptosis of Cetuximab[1]. |
| References |
| No Any Chemical & Physical Properties |